Cardinal Health (CAH)
(Delayed Data from NYSE)
$113.17 USD
+0.78 (0.69%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $113.24 +0.07 (0.06%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$113.17 USD
+0.78 (0.69%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $113.24 +0.07 (0.06%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Zacks News
Cardinal Health (CAH) Tops Q1 Earnings, Misses on Sales
by Zacks Equity Research
Cardinal Health's (CAH) pharmaceutical segment revenues increased in the first quarter due to strong growth from the Specialty business and higher number of Pharmaceutical Distribution business customers.
What's in Store for Cardinal Health (CAH) in Q1 Earnings?
by Zacks Equity Research
Cardinal Health (CAH), a global player in the healthcare services and products space, has been grappling with pricing deflation in the generics segment in the first quarter.
Why Is Cardinal Health (CAH) Down 2.7% Since the Last Earnings Report?
by Zacks Equity Research
Cardinal Health (CAH) reported earnings more than a month ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cardinal Health (CAH) Beats on Earnings & Revenues in Q4
by Zacks Equity Research
Cardinal Health (CAH) reported strong fourth quarter results, beating the Zacks consensus estimate on both counts. Solid growth in the company's Pharmaceutical and Medical segments were the key catalysts.
Cardinal Health (CAH) Tops Q3 Earnings, Miss on Revenues
by Zacks Equity Research
Cardinal Health???s adjusted earnings rose 7% on a year-over-year basis to $1.53 per share.
Medical Product Stocks' Earnings Due on May 1: CAH & OCPNY
by Zacks Equity Research
Here we take a look at two major Medical Product bigwigs, which are expected to release their earnings results on May 1.
Why Cardinal Health (CAH) Might Surprise This Earnings Season
by Zacks Equity Research
Cardinal Health (CAH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Why Is Cardinal Health (CAH) Up 4.4% Since the Last Earnings Report?
by Zacks Equity Research
Cardinal Health (CAH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cardinal Health (CAH) Q2 Earnings Beat Estimates, Rise Y/Y
by Zacks Equity Research
Cardinal Health Inc. (CAH) reported second-quarter fiscal 2017 adjusted earnings of $1.34 per share, which beat the Zacks Consensus Estimate of $1.24 and increased 3% on a year-over-year basis.
Cardinal Health (CAH) Tops Q2 Earnings, Miss on Revenues
by Zacks Equity Research
Cardinal Health???s adjusted earnings rose 3% on a year-over-year basis to $1.34 per share.
Start the Week with These Perfect Earnings Charts
by Tracey Ryniec
Who's been able to beat earnings every quarter for 5 years?
Cardinal Health (CAH) Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Cardinal Health (CAH), a global player in the healthcare services and products space, is set to report second-quarter fiscal 2017 results on Feb 7, before the bell.
McKesson (MCK) Q3 Earnings: Stock Likely to Disappoint?
by Zacks Equity Research
McKesson Corporation (MCK), one of the largest healthcare services providers, is scheduled to report third-quarter fiscal 2017 results on Jan 25.
Should Value Investors Pick Cardinal Health (CAH)?
by Zacks Equity Research
Cardinal Health is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front.
Top Research Reports for November 14, 2016
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Procter & Gamble (PG), Berkshire Hathaway (BRK.B) and Altria (MO).
Company News for November 01, 2016
by Zacks Equity Research
Companies In The News are: LVLT,CTL,CAH,CHKP,DO
Top 3 Research Reports for August 8, 2016
by Sheraz Mian
Today's must-read reports are for MasterCard (MA), Bank of America. (BAC) and Kraft Heinz (KHC).